Search results

Crearene is a pioneering, patient centric medical technology company, with the mission to bring the human dimension into dialysis treatments. Following a successful safety, feasibility, and dose-finding clinical study, Crearene now intends to launch its fist commercial offering into the market.

OnconiX AG transforms cancer care by replacing trial-and-error with test-before-treat precision. Using patient-derived tumor models and AI, we predict treatment response in days, enabling personalized therapy selection that improves outcomes and reduces unnecessary toxicity for patients with cancer.

VERAXA is a Swiss/German clinical-stage company advancing next-generation antibody therapies to fight cancer through groundbreaking innovations. Using a dual-targeting approach, our BiTAC-TCE, BiTAC-ADC, and bsADC platforms are powered by proprietary chemical bioconjugation and linker technologies.

Nanolynx is developing conditionally active nanobody-drug conjugates that overcome the tissue penetration and toxicity limits of conventional ADCs, enabling safer and more efficacious therapies for hard-to-treat cancers.

R&D oriented SME developing a portfolio of vaccines against infectious diseases. Dengue vaccine already on the market since 2024 and distributed via partenrs in Ais and Latin-America.

Combioxin is a clinical-stage biotechnology company dedicated to the development of first-in-class life-saving drugs for critically ill patients.

Melodia Therapeutics is advancing a next-generation DPP1 inhibitor to transform the treatment of severe neutrophil-driven inflammatory diseases.

MicroElectrodeDevices produces and markets microelectrode array biochips for electrophysiological monitoring of neuronal cells/tissues in vitro.

Looking for cheap lab space in Basel? Lambda Biolab (a service of Mackenzie-Lamb Consulting) offers affordable, fully equipped BSL-1 benches for researchers and biotech entrepreneurs for a fraction of the cost of traditional labs. Reduced rates for students, artists, and non-profits are available.

Ai.Qimia is advanced fine-grained prediction for Process Chemistry. We provide physics-based AI tools and quantum simulation to address challenges in forward synthesis that confound the efficient development of new drugs to market.

HemostOD is a seed financed start-up developing in-vitro human platelets. It has 10 staff, 8 of which are based at laboratories on the EPFL Innovation park in Lausanne. With operations commencing in 2021, HemostOD's next milestone is a pre-IND meeting in 2026 and commencement of IND studies.

Arakena Pharmaceuticals GmbH is a Basel-based biopharma start-up, focusing on the discovery and development of innovative small molecular weight compounds as first-in-class treatment for cardiomyopathies, cardiovascular and metabolic diseases.

At OBaris, we are revolutionizing peptide drug delivery with OctoPatch®—a painless, patient-friendly platform designed to replace injections. Our innovative technology enables pharma partners to target various diseases, improving patient compliance and treatment outcomes.

THE CULTURED HUB works with a global network of start-ups to find answers to the food industry’s most pressing questions in order to define the food of the future. We are a scale up as a service company for industrial biotech, accelerating the development of sustainable foods through biotech.

Discover if your new anti-cancer drug will work! Our validated platform uses intact patients tumors, maintains their complexity and cellular component, and overcomes organoids. This allows to reliably assess at the pre-clinical stage the efficacy of drugs in patients.

We are using ethical and representative AI technology to pioneer groundbreaking health ventures that transform health journeys, empowering communities in the global south. Our cutting-edge technology can address complex healthcare challenges and make a meaningful impact on people's lives.

LifeMine is a biopharmaceutical company that leverages evolutionary insights from fungi to unearth next-generation precision medicines. Through our discovery engine, we are uniquely positioned to bring novel precision medicines to patients in urgent need of breakthrough disease intervention.

Inova Consulting – Your premier Swiss consulting partner, specializing in the life sciences industry. Our team of Swiss-based experts. Excels in compliance, validation, engineering, and digitalization. With our AI boosters, we deliver exceptional added value for your projects.

Hemetron AG offers a unique at-home blood test solution that empowers patients with chronic inflammatory conditions to monitor their inflammation levels, enabling precise, personalized treatment adjustments for improved outcomes at lower costs.

Cureteq is an asset management and biotechnology company developing innovative medicines based on a sophisticated artificial intelligence platform. Cureteq leverages artificial intelligence to identify the optimal applications of a given molecule and to de-risk clinical development.

Abrinca Genomics has disrupted microbial genomics research with OpenGenomeBrowser, a powerful tool for genome data management and genomic analytics. Its user-friendly interface seamlessly enhances your ability to derive new insights from well-organized data to speed up innovation and discovery.

At RGCC, we are at the forefront of revolutionizing healthcare through personalized solutions for cancer and chronic diseases. Our commitment is global, aiming to provide personalised, diagnostic and therapeutic options to patients worldwide.​

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

Renaldee is bringing the first natural active form of Vit. D (1,25-dihydroxyvitamin D3) into a human pharma market extracted entirely from a plant, solanum glaucophyllum. Our offering is not to be confused with the inactive form of Vit. D which you can buy over the counter.

AdRegeneer exists to redefine neuroregeneration and restore hope for patients suffering from neurodegenerative diseases. We believe that regeneration is possible, and we are committed to developing innovative, patient-centric therapies that go beyond symptom management.

Adjuvants are key ingredients of vaccines, improving the duration of immune responses or making vaccines cheaper to produce. VFI’s mission is to develop high-quality adjuvants for the benefit of the vaccine community and make them accessible under equitable and open-access terms.

Founded in August 2022, Moonlight AI is specialising in haematology & cytology. Aiming for a market launch in 2024-25, Moonlight AI's genomic biomarker and diagnosis solutions promise to revolutionize cancer diagnostics by addressing significant gaps in molecular testing for accurate patient care.

Metadvice Companion AI is distilling complex disease treatment outcome data into actionable insights shared with clinicians & patients, sourcing data from a growing global network of leading practitioners to take precision medicine to the next level!

Bewelab develops evidence-based digital solutions to reduce unhealthy consumption behaviours. This innovation is delivered through engaging, professional smartphone video games that ensures high accessibility. Bewelab was founded by researchers in Neuroscience from the University of Fribourg.

We produce medical cannabis as a recognized remedy for the benefit of patients. Canexis is committed to bringing the highest quality cannabinoids to the market for medical purposes. To ensure this, we work consistently in accordance with the EU or PIC/S-GMP (part 1 & part 2) regulations.

CompagOs, a Swiss spin-off from ETH Zürich, offers preclinical research services and develops diagnostic tools in the domain of bone health, utilizing proprietary in vitro models.

We carry out technology transfers in the pharmaceutical industry, including: Process development & process optimizations - Scale up - Find the right CDMO - Transfer the technology to the manufacturing site - Provide all tests and documentation

Matrix Fine Chemicals is an innovative supplier of speciality fine chemicals and bespoke, complex, multi-step organic synthesis. Since 2001, we are the preferred partner for pharmaceutical, personal care, agrochemical, life science companies of all sizes.

TheraMe! AG, a spin-off from EPFL, is a MedTech startup based in Lausanne that provides personalized cancer therapy recommendation based on functional drug screening directly from patient biopsy using microfluidic technologies.

Inhalis is committed to improve patients’ life with safer and more effective treatment options. Solid science and industry-leading delivery technology are combined with an experienced management team to research and develop new inhaled treatments for IPF and other life-threatening diseases.

Swiss Bioscience was established in 2014 in Switzerland and is specialized in producing pharmaceutical quality grade stems cells under cGMP* conditions. The cells are isolated from human adipose tissue to produce SVF which is then purified and expanded to produce hADSCs.

3B Biotech is a Swiss based full service Contract Research Organization, Regulatory affairs and Pharmacovigilance specialist. Our solutions support pharma, biotech, medical and nutritional companies during the development, research, marketing and post-marketing programs. 

LaRive Bio is a clinical development and licensing organization founded in 2021 and based in Zug. We seek to identify, license in/acquire, develop and license out molecules in areas of significant unmet medical need, applying an abbreviated regulatory pathway. At present, focus lies on neurology.

Switzerland Innovation is a network of six innovation parks and 16 sites, with access to the expertise of world's leading universities, forming an ecosystem accelerating the transformation of research results into marketable products and services.

Smart sensor solutions - Increase health, improve energy efficiency, ensure safety & comfort – for a better tomorrow.

We are focusing on worldwide sourcing,distributing and custom manufacturing of fine chemicals, intermediates, ingredients, specialities, niche APIs and NCE’S since 1997.

The main purpose of Genolier Innovation Hub is to gather the most important stakeholders of the Medtech, Pharma and Bioscience fields within its walls.

Micreos is a platform biotech focused on discovering & developing recombinant proteins for chronic Dermatology, Oncology & Respiratory conditions

We are developing radiotracers for early detection of neurodegenerative disorders. This diagnosis is performed using PET imaging to visualize specific brain receptors. We see Nemosia as the missing piece to support drug development, therapy monitoring patient recruitment.

We are a National Center of Excellence for Translational Medicine that accelerates and streamlines research for the benefit of patients, society and science. Located on the Insel Campus Bern, a wide variety of units from the hospital, industry, research, and education are networked under our roof.

BioFi’s proprietary technology Endogenics™ is a novel approach to virtual modeling and simulation for living organisms. From simple single cells to complex and dynamic multicellular systems. We work across Life Sciences industries to investigate biological mechanisms, generating knowledge and IP.

GRIFFON develops peptides against metabolic disorders.

Resmonics' mission is to unlock the power of sound for medicine. Our product ResGuard Med is a CE-certified medical software that uses acoustic artificial intelligence to detect lung symptoms and assess their severity.

Our vision is to make functional imaging accessible for people worldwide and create a lasting social impact. We advance clinical routine and enable research in diagnostics, treatment monitoring and the development of new therapies. Positrigo makes functional imaging scalable – imaging everyone!

At Sleepiz, we believe that remote monitoring has tremendous potential to improve standards of care. That's why we're breaking new ground by transitioning from traditional wearables to contactless surveillance.

We turn insights into action in the fight against hypertension. At Aktiia, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care.

Endogena is a clinical-stage biotechnology company that discovers and develops first-in-class endogenous regenerative medicines to repair diseased tissues. Our unique approach has the potential for a paradigm shift in how degenerative conditions due to aging and genetic disorders are treated.

Hengrui Europe Biosciences is a biotech start-up based in Zurich, Switzerland, established in 2021. We are a subsidiary of Jiangsu Hengrui Pharmaceuticals Co., Ltd. and are building a new research center with a differentiated technology platform to support innovative antibody discovery research.

Contract R&D facility in the heart of a Vaud life science cluster.

Cell Receptor Inc. has IP for remarkably improving treatment results in oncology by targeting critical upstream steps of growth signaling, not noticed in oncology yet. A well-tolerated affordable treatment of low toxicity! It will prevent metastasis and chemoresistance in most cancers.

Biotechnet Switzerland is an association of Swiss Universities of Applied Sciences, Universities, and Research and Technology Organizations. Industrial partners can rely on our proven expertise and outstanding infrastructure to support innovative research & development projects.

Sysmatec offers laboratory automation systems and software, scientific software and a wide range of laboratory equipment (material for biotechnology, chemistry…). The most devices presented here can be connected to a computer with our software.

Diaxxo has developed a fast, affordable and accurate point-of-care (PoC) polymerase chain reaction (PCR) device that diagnoses several diseases with a simple sample-to-result approach and without the need of a cold chain.

DBI was founded as a spin-off of USZ/UKBB and ETH in 2018 with the vision to uncover the full potential of Molecular Breath Analysis to advance precision medicine and make it available for general health care. The core competences are in patterned analytical analysis of data with highest accuracy.

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.

IST AG is your sensor and technology partner for temperature, flow, conductivity and metabolite sensors. Ready-to-use and custom sensor solutions with competent support for single-use sensor design, integration into process control (PAT) and laboratory analytical systems.

Quercis Pharma AG is a private Swiss biotech company advancing a novel antithrombotic in multiple indications: the lead program is prevention of Venous Thrombosis Embolism in advanced cancer patients (phase III) followed by clinical trials in Sickle Cell Disease (phase II) and Covid-19 (phase II).

Axenoll Life Sciences AG revolutionizes 3D Mass Customization by the globally first industrial highly parallel additive mass customization of highly idential high quality items under GMP and sterile conditions using cellular or molecular materials for analytical, diagnostic or medical application.

lino Biotech is the world's only provider of Focal Molography – a novel label-free biosensor platform for direct imaging of biomolecular interactions in living cells, enabling our customers to measure molecular interactions in a more robust and more sensitive way while offering unique information. lino Biot

MimiX leverages Sound Induced Morphogenesis (SIM), a proprietary technology that uses sound in conjunction with cells, stem cells, spheroids, organoids & bioactives, to create tissue-relevant architectures (bio-patterns).

GaDia is the first company helping healthcare professionals to diagnose healthcare-acquired fungal infections in 15 minutes.

Clemedi combines DNA sequencing and artificial intelligence to recommend the optimal antibiotic therapy for every patient. Our products help with managing infectious diseases such as tuberculosis, sexually transmitted infections or hospital acquired infections.

ABCDx is specialized in the discovery, clinical validation and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for acute brain injuries such as trauma and stroke.

Cellis is developing Macrophage Drug Conjugates (MDCs) which is a breakthrough, new class of therapy for solid tumors. Cellis uses allogeneic macrophages conjugated with therapeutic medications for treatment of several solid tumors. Our focus is on glioblastoma, ovarian and pancreatic cancer.

Binz Biotech Consulting GmbH offers life science management consultancy. Its mission is to support the success of your business. The consulting portfolio of Binz Biotech Consulting is based on hands-on biotech company-building experience. Consulting is provided for biotech, pharma as well as VCs.

ariadne.ai ag offers cutting-edge biomedical image processing technology - scalable in throughput, consistent in quality. Our machine-learning experts and scientists combine human and artificial intelligence to turn terabytes of microscopy data into quantitative results.

UFAG Laboratorien AG provides Analytical Services for the Pharmaceutical, Biotech, and Medical Device Industries including QC of raw materials/products, method development/validation, stability studies, bioanalytical and biosimilar testing, for small and bio-molecules (e.g. oligonucleotides, mAB).

Mother company for a range of department: www.CerCell.com, www.PerfuseCell.com, www.ProlifeCell.com, www.PumpCell.com, www.Cronus-pcs.com all concerned with customized a variaty of SUBs, SUFs, SUMs, PCSs ranging 500 ml to 30 liter Vessel Volume as well as accessories and drive systems.

Changing preterm birth diagnostics: We are working hard to modernize the tools that help pregnant women anticipate the risk of a premature birth. Our team is born from two of the most recognized institutions in Switzerland, the EPFL and the CHUV.

NxR Biotechnologies®, assists companies or academia in business development or investment initiatives, strategic, scientific, and commercial projects, with a focus on ATMPs. In parallel, NxR conducts internal R&D in oncology. Track record comprises projects with big pharmas, generic companies, financial

OxyPrem AG is the manufacturer of OxyPrem 1.4, a novel non-invasive tissue oximeter to determine oxygen saturation in human tissue. Its unmatched precision and reliability allow clinicians to make better decisions when assessing tissue or body parts which are at risk of oxygen under- or oversupply.

On mandates of chemical, pharmaceutical, agrochemical and biotechnology industries, we study the electrochemical alternative for redox transformation steps and waste water treatment of refractory organic compounds. We perform process optimization in the laboratory and conduct the scale-up to the industrial le

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell and multi-omics data. We have a diverse and multi-disciplinary team, supported by world-leading scientific advisors and reputable investors.

KYLYS is a Life Science spin-off from the University of Geneva developing a unique technology for delivering highly effective and safe products based on hyaluronic acid (HA). Our product lines include medical treatments (KYLYS) and aesthetic solutions (KYLYS AESTHETICS).

A Swiss life science consultancy helping pharma and biotech clients developing TPP, CDP, clinical trial designs and clinical trial protocols for drug development programs.

Endotelix is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Endotelix is dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome, including diagnostic tests and therapies.

Cureab is a biotech company focused on discovering and developing antibodies in oncology until late pre-clinical stage.

AgroSustain – a one-stop-shop solution for natural plant protection. We aim to reduce food waste and support sustainable food production by developing farm-to-fork solutions, like biostimulants and coatings.

Aprofol AG is focused on bioactive (reduced) Folates. Local or systemic folate deficiencies have a strong influence on the progression of chronic diseases. Deep knowledge of the properties of the Folate forms makes the development of promising treatments for eye disease and autism (ASD) possible.

Our first bioreactor was introduced in 1965. Ever since, we have worked closely with scientists around the world to address research challenges to provide intelligent bioprocessing solutions.

“Chemical free” and “GMO free” products for agriculture, environmental bioremediation, livestock, oenology, food preservation. Our products optimize all biological processes, promote the indigenous microbiology and allow the achievement of an optimal balance in the biomass system.